But this is a massive deal. General catalyst and trillion taking Janus Henderson, an asset manager private. I mean, do they need access to the the funds that Janus Henderson would have in reserve.Yeah. I mean, I can imagine, Vonnie, that the private equity group is very much interested in the funds under management by Janus Henderson, and it really just speaks to kind of the broader, evolving, just the landscape of finance. Right.We we have seen a lot more institutional investors, the likes of pension funds ...

Group 1: Private Equity and Asset Management - General Catalyst and Trillion are taking Janus Henderson, an asset manager, private, indicating a significant interest in the funds under management by Janus Henderson [1] - There is a growing trend of institutional investors, such as pension funds, exploring private equity due to the potential for higher rewards, despite the associated risks [2][3] - The interest in Janus Henderson's assets is likely to attract private equity firms and investors, reflecting a broader trend of increased M&A and IPO activity in the market [3] Group 2: Market Trends and Predictions - The S&P 500 has delivered annual gains in seven out of the last ten years, with forecasts suggesting an 11% gain for the index, which is half of the gains seen in the previous two years [5][7] - Despite a generally bullish outlook, there are lingering uncertainties and fragilities in the market that temper this optimism [6][8] - The potential removal of tariffs is viewed positively, with expectations that it could improve risk sentiment and lead to higher S&P 500 performance [8]

Exclusive: Energy Capital Partners’ deal for Calpine is poised to become the most profitable private-equity deal of all time by dollar value https://t.co/zOdv4OqdWi ...

A group of private equity firms led by Permira and Warburg Pincus agreed to buy Clearwater Analytics Holdings Inc. in a deal valuing the company at $8.4 billion including debt. https://t.co/rUbc55vURQ ...

Private equity firms and other investors have bought and sold a record volume of US industrial and infrastructure assets this year. https://t.co/aJe79xrCOH ...

Joining us right now with a look back and a look ahead is the firm's CEO, chairman, and co-founder, Steve Schwarzman. And Steve, thank you for taking the time to sit down with us. >> Well, it's fun for me. >> It is fun for us, too.We don't get the chance to do this very often. Um, 40 years since you built this firm, uh, coming out with $400,000 in capital where you sat down and kind of branched out into this new and fledgling private equity world that you helped build. What do you think 40 years later with ...

Demand for AI infrastructure keeps growing, but a bit of a red flag is being raised on financing some of these data centers. Diana Ol here now with the property play on data centers. Diana, you just heard all that discussion and we talked so much about all the investors getting in, but there are also now some that are either getting out or sitting out.>> Yeah. I mean, look, Brian, you know, I am all about the buildings. That's all I focus on.And I'm hearing that commercial real estate investors are increasi ...

Turn to Dan Primac. He's the business editor at Axios who brought our attention to the boring IPO boom last week. Dan, um, does it become much more buzzy next year.>> I think so. And I think, as Leslie said, I think you're going to see more of these deals. I mean, it's worth noting Medline was kind of exceptional in private equity terms anyway, right.This was a deal that was done in 2021. It was a return of so-called club deals. I believe it's the largest healthcare leverage buyout ever.Um, so it was a very ...

The largest IPO of the year, Medline, opening for trading about 15 minutes ago at $35 per share. That's up more than 20% from its IPO price of $29 per share. The company, which makes supplies products uh supplies and products used in labs and surgeries, sold more shares than initially planned in an upsized deal, more than $6 billion worth.Medline has been private for 58 years with most of its tenure familyowned until its buyout by a consortium of private equity firms in 2021. The IPO market cap is about 20 ...

THAT HAS BEEN A BIG CHALLENGE OVER THE PAST FEW YEARS, LEADING TO QUITE THE BACKLOG. >> INDEED, IN THAT SENSE, A VERY BIG DEAL HERE. LESLIE.THANK YOU. LET'S ALSO TURN TO DAN PRIMACK. HE'S THE BUSINESS EDITOR AT AXIOS WHO BROUGHT OUR ATTENTION TO THE BORING IPO BOOM LAST WEEK.DAN, DOES IT BECOME MUCH MORE BUZZY NEXT YEAR. >> I THINK SO, AND I THINK, AS LESLIE SAID, I THINK YOU'RE GOING TO SEE MORE OF THESE DEALS. I MEAN, IT'S WORTH NOTING MEDLINE WAS KIND OF EXCEPTIONAL IN PRIVATE EQUITY TERMS ANYWAY, RIGHT. ...